Search

everythinglearnresearchcommunity

for

Search:↓

A man's scalp hair loss was due to a combined melanocytic nevus and alopecia areata, suggesting a possible link between the two conditions.

About 17% of people in France have dandruff, and those with dandruff are more likely to have sensitive and itchy scalps.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

The woman was diagnosed with lichen planopilaris and can be treated with corticosteroids.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

A woman's hair loss was due to trichotillomania, which is often misdiagnosed and can require different treatments based on age and underlying conditions.

Scalp reduction can improve hair distribution in certain baldness cases but requires careful patient selection and understanding of facial structure.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Finasteride helps 83% of men maintain or increase hair count.

Topical spironolactone effectively treats hair loss in women.

Minoxidil helps 32% of patients with hereditary baldness regrow hair.

Exprecell™ is as effective as traditional methods but produces more f-PRF and is simpler to use.

The device mimics human hair follicles and detects tiny forces and moments with high sensitivity.

Liposomes can safely and effectively deliver substances to mouse hair follicles, potentially useful for human hair treatments.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.

High TNF-α levels may increase hair loss risk after PRP therapy.

Invasomes loaded with clotrimazole gel could improve drug delivery through the skin for fungal treatment.

PRP injections improve hair density in men with hair loss, with few short-term side effects.

Gas-propelled dissolving microneedles improve drug loading and delivery efficiency.

The new device can implant cell mixtures more effectively for hair loss treatment and is easier for operators to use.

Bubble microneedles effectively deliver drugs through the skin and mouth, improving treatment speed and efficiency.

Deformable vesicular carriers improve drug delivery for skin conditions and systemic treatments.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

Horizontal scalp biopsy sections effectively diagnose and predict MPAA, with follicular density and inflammation impacting hair regrowth.

FPHL affects hair density and diameter, causing visible hair loss in older women.